Morning Overview on MSN
The two drugs that just cleared Alzheimer’s plaques in mice already sit in pharmacies as cancer treatments — a shortcut that could reach patients years sooner
In 2012, neuroscientist Gary Landreth and his team at Case Western Reserve University published a finding in Science that ...
A newly identified enzyme called IDOL could become a major new target in the fight against Alzheimer’s disease. Researchers ...
Morning Overview on MSN
Scientists just flagged an enzyme called IDOL as a powerful new Alzheimer’s target — one that controls how the brain handles toxic cholesterol
Nearly seven million Americans are living with Alzheimer’s disease, and the handful of treatments approved in recent years ...
A new nanotechnology treatment reversed Alzheimer’s symptoms in mice by restoring the brain’s natural cleanup system. The specially engineered nanoparticles helped clear toxic amyloid proteins from ...
The retraction came from Neurobiology of Aging, which removed a 2011 paper claiming to show that a version of a protein ...
Scientists in Japan found that arginine, a common amino acid already used in supplements and medicine, reduced harmful ...
A group from Osaka Metropolitan University in Japan, led by graduate student Tatsushi Oura and Dr. Hiroyuki Tatekawa, found that treatment using the drug lecanemab to remove amyloid plaques in the ...
Lecanemab, sold under the name Leqembi, is a monoclonal antibody therapy for Alzheimer's disease that clears toxic amyloid plaques and delays cognitive decline. Researchers from VIB and KU Leuven have ...
Eli Lilly has launched Lormalzi (donanemab) in India for early Alzheimer's disease at Rs91,688 per vial. The once-monthly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results